Avatar
Camplocust8

0 Following 0 Followers
1
Lignant potential in tumors. Well differentiated carcinomas are regarded as low malignant potential and conversely poor differentiated carcinomas as high malignant potential in ovarian carcinomas [26]. In the well differentiated carcinoma group the percentage of ALDH1 high expression cases in tumor cells (31.6 ) was much higher than the percentage in the moderate differentiation group (11.3 ) an
1
Lignant potential in tumors. Well differentiated carcinomas are regarded as low malignant potential and conversely poor differentiated carcinomas as high malignant potential in ovarian carcinomas [26]. In the well differentiated carcinoma group the percentage of ALDH1 high expression cases in tumor cells (31.6 ) was much higher than the percentage in the moderate differentiation group (11.3 ) an
1
Lignant potential in tumors. Well differentiated carcinomas are regarded as low malignant potential and conversely poor differentiated carcinomas as high malignant potential in ovarian carcinomas [26]. In the well differentiated carcinoma group the percentage of ALDH1 high expression cases in tumor cells (31.6 ) was much higher than the percentage in the moderate differentiation group (11.3 ) an
1
Ion levels in ovarian carcinoma cells and the clinical and pathologic characteristicsALDH1 IHC score in tumor cells 1 (negative) Number Age (years old): 39 40?9 50?9 60?9 70 missing Histological subtype: Serous carcinoma Mucinous carcinoma Endometrioid carcinoma Clear cell carcinoma Mixed epithelial tumor Undifferentiated tumor Unclassified tumor and others FIGO Stage: I II III IV Not staged or mi
1
Ion levels in ovarian carcinoma cells and the clinical and pathologic characteristicsALDH1 IHC score in tumor cells 1 (negative) Number Age (years old): 39 40?9 50?9 60?9 70 missing Histological subtype: Serous carcinoma Mucinous carcinoma Endometrioid carcinoma Clear cell carcinoma Mixed epithelial tumor Undifferentiated tumor Unclassified tumor and others FIGO Stage: I II III IV Not staged or mi
1
Was 0.507 year to 0.793 year.Huang et al. BMC Cancer (2015) 15:Page 4 ofFig. 1 ALDH1 expression in ovarian carcinoma cells and stromal cells. a A poor differentiated ovarian carcinoma showed negative immunostaining in tumor cells for ALDH1, while most of the stromal cells surrounding tumor cells were strongly positive (100?. b High magnitude was used in the same case in A, showing clear negative t
1
W expression and high expression of ALDH1 in the stromal cells were 13 cases, 61 cases and 174 cases, respectively (Table 3).ALDH1 expression was not associated with the agesFIGO stage, as the most popular clinically used stage criteria is an important prognostic predictor in ovarian carcinomas [25]. High expression of ALDH1 in ovarian carcinoma cells was significantly associated with early FIGO s
1
Ion in the stromal cells was not associated with the differentiation grade (p > 0.05, linear by linear association, Table 3).ALDH1 expression in ovarian carcinoma cells was associated with better survivalsOvarian carcinoma patients involved in our study were diagnosed and verified as several subtypes by histology: serous carcinoma, mucinous carcinoma, endometrioid carcinoma, clear cell carcinoma,